ampyra logo
ampyra logo
A woman walks through tall grass, holding flowers.A woman walks through tall grass, holding flowers.

Hello !

Welcome to your MyAmpyra dashboard—and welcome to a community that’s here to support you on your AMPYRA treatment journey

Actor portrayal
green-saperation-imagegreen-saperation-image

Tracking your progress on MyAmpyra

Using your Personal Walking Assessment

It's important to recognize changes in your walking due to multiple sclerosis (MS). You can use this assessment to track progress throughout treatment with AMPYRA, answering questions like:

  • Have changes to my walking impacted my activities?
  • Has my walking improved, stayed the same, or gotten worse?
  • Are there certain days or times when my walking becomes slower?

Simply fill out the assessment and either print it out or e-mail it to your doctor. Completing this assessment regularly can help you and your doctor track any changes to your walking while using AMPYRA.

Get started filling out your Personal Walking Assessment to help make the most of your next appointment.

Begin Your Personal Walking Assessment

Start
The feet of a woman as she steps towards a group of people ahead of her.

Keep a journal

Journaling about your walking can be a good way to reflect and keep track of any changes that you notice throughout treatment with AMPYRA. Don't know what to write? Here are some ideas to help you get started.

  • Track walks you take throughout the week and log any changes you notice.
  • Reflect on your personal experiences about MS and your walking.
  • Jot down inspirational quotes that help keep you motivated to walk.
The feet of a woman as she steps towards a group of people ahead of her.
Actor portrayal

Download resources

Below are some helpful resources for your journey. Explore these downloadable tools to help get you started with AMPYRA.

Patient Brochure Image
Patient Brochure

See helpful information about getting started with AMPYRA.

Download
Patient Brochure Image
Patient Medication Guide

Patients should read this information before starting AMPYRA.

Download
INDICATION & IMPORTANT SAFETY INFORMATION
Indication: AMPYRA (dalfampridine) is a prescription medicine indicated to help improve walking in adults with multiple sclerosis (MS). This was demonstrated by an increase in walking speed.
Important Safety Information

Do not take AMPYRA if you:

  • have ever had a seizure,
  • have certain types of kidney problems, or
  • are allergic to dalfampridine (4-aminopyridine), the active ingredient in AMPYRA.

Take AMPYRA exactly as prescribed by your doctor.

Before taking AMPYRA, tell your doctor if you:

  • have any other medical conditions
  • are taking compounded 4-aminopyridine
  • are taking any other prescription or OTC medicines, such as cimetidine
  • are pregnant or plan to become pregnant. It is not known if AMPYRA will harm your unborn baby.
  • are breastfeeding or plan to breastfeed. It is not known if AMPYRA passes into your breast milk. Talk with your healthcare provider about the best way to feed your baby if you take AMPYRA.

Stop taking AMPYRA and call your doctor right away if you have a seizure while taking AMPYRA. You could have a seizure even if you never had a seizure before. Your chance of having a seizure is higher if you take too much AMPYRA or if your kidneys have a mild decrease of function, which is common after age 50. Your doctor may do a blood test to check how well your kidneys are working before you start AMPYRA.

AMPYRA should not be taken with other forms of 4-aminopyridine (4-AP, fampridine), since the active ingredient is the same.

AMPYRA may cause dizziness or vertigo. If you have these symptoms do not drive, operate machinery or do other dangerous activities.

AMPYRA may cause serious side effects, including severe allergic reactions. Stop taking AMPYRA and call your doctor right away or get emergency medical help if you have shortness of breath or trouble breathing, swelling of your throat or tongue, or hives.

The most common side effects for AMPYRA in MS patients were urinary tract infection; trouble sleeping; dizziness; headache; nausea; weakness; back pain; problems with balance; multiple sclerosis relapse; burning, tingling, or itching of your skin; irritation in your nose and throat; constipation; indigestion; and pain in your throat.

Please see the Patient Medication Guide.

INDICATION

AMPYRA® (dalfampridine) Extended Release Tablets, 10 mg, is the first and only brand prescription medicine indicated to help improve walking in adults with multiple sclerosis (MS). This was demonstrated by an increase in walking speed.

IMPORTANT SAFETY INFORMATION

Do not take AMPYRA if you have ever had a seizure, have certain types of kidney problems, or are allergic to dalfampridine (4-aminopyridine), the active ingredient in AMPYRA.

SEE MORE